tiprankstipranks
Agilon Health Inc (AGL)
NYSE:AGL
US Market
Want to see AGL full AI Analyst Report?

Agilon Health (AGL) Stock Statistics & Valuation Metrics

378 Followers

Total Valuation

Agilon Health has a market cap or net worth of $1.35B. The enterprise value is $1.17B.
Market Cap$1.35B
Enterprise Value$1.17B

Share Statistics

Agilon Health has 16,683,786 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,683,786
Owned by Insiders
Owned by Institutions

Financial Efficiency

Agilon Health’s return on equity (ROE) is -3.20 and return on invested capital (ROIC) is -196.72%.
Return on Equity (ROE)-3.20
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-196.72%
Return on Capital Employed (ROCE)-2.16
Revenue Per Employee5.51M
Profits Per Employee-363.71K
Employee Count1,076
Asset Turnover4.67
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Agilon Health is 1.1. Agilon Health’s PEG ratio is -0.01.
PE Ratio1.1
PS Ratio0.05
PB Ratio2.25
Price to Fair Value2.25
Price to FCF-2.40
Price to Operating Cash Flow-26.72
PEG Ratio-0.01

Income Statement

In the last 12 months, Agilon Health had revenue of 5.93B and earned -405.35M in profits. Earnings per share was -24.50.
Revenue5.93B
Gross Profit-188.61M
Operating Income-421.08M
Pretax Income-404.10M
Net Income-405.35M
EBITDA-368.86M
Earnings Per Share (EPS)-24.50

Cash Flow

In the last 12 months, operating cash flow was -50.05M and capital expenditures -26.56M, giving a free cash flow of -76.61M billion.
Operating Cash Flow-50.05M
Free Cash Flow-76.61M
Free Cash Flow per Share-4.59

Dividends & Yields

Agilon Health pays an annual dividend of $0.45, resulting in a dividend yield of ―
Dividend Per Share$0.45
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.56
52-Week Price Change46.49%
50-Day Moving Average30.16
200-Day Moving Average23.42
Relative Strength Index (RSI)76.15
Average Volume (3m)545.26K

Important Dates

Agilon Health upcoming earnings date is Jul 30, 2026, After Close (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date

Financial Position

Agilon Health as a current ratio of 1.02, with Debt / Equity ratio of 18.41%
Current Ratio1.02
Quick Ratio1.02
Debt to Market Cap0.12
Net Debt to EBITDA0.37
Interest Coverage Ratio-63.41

Taxes

In the past 12 months, Agilon Health has paid 1.25M in taxes.
Income Tax1.25M
Effective Tax Rate>-0.01

Enterprise Valuation

Agilon Health EV to EBITDA ratio is -0.40, with an EV/FCF ratio of -1.25.
EV to Sales0.02
EV to EBITDA-0.40
EV to Free Cash Flow-1.25
EV to Operating Cash Flow-1.40

Balance Sheet

Agilon Health has $302.99M in cash and marketable securities with $33.40M in debt, giving a net cash position of $269.59M billion.
Cash & Marketable Securities$302.99M
Total Debt$33.40M
Net Cash$269.59M
Net Cash Per Share$16.16
Tangible Book Value Per Share$3.68

Margins

Gross margin is -2.74%, with operating margin of -7.10%, and net profit margin of -6.83%.
Gross Margin-2.74%
Operating Margin-7.10%
Pretax Margin-6.81%
Net Profit Margin-6.83%
EBITDA Margin-6.22%
EBIT Margin-6.70%

Analyst Forecast

The average price target for Agilon Health is $50.96, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$50.96
Price Target Upside69.59% Upside
Analyst ConsensusHold
Analyst Count15
Revenue Growth Forecast-2.82%
EPS Growth Forecast-45.70%

Scores

Smart Score7
AI Score